default author photo

Sudhir Babji

Christian Medical College - The Wellcome Trust Research Laboratory

SCHOLARLY PAPERS

1

DOWNLOADS

118

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Immunogenicity and Safety of Homologous and Heterologous Booster Vaccination of ChAdOx1 nCoV-19 (COVISHIELD TM) and BBV152 (COVAXIN®) in Previous Recipients of COVISHIELD TM or COVAXIN®: A Phase 4, Participant and Observer Blinded, Randomised Study

Number of pages: 27 Posted: 22 Jun 2022
Winsley Rose, Reshma Raju, Sudhir Babji, Anna George, Ramya Madhavan, Julian Vivek Leander Xavier, Jenita Sharon David Chelladurai, Origanti Sharon Nikitha, Arpitha Anbu Deborah, Shalini Vijayakumar, Sushil Immanuel, Jacob John, Priscilla Rupali, Kundavaram Paul Prabhakar Abhilash, Venkata Raghava Mohan, Karthik Bharadwaj Tallapaka, Prasanna Samuel and Gagandeep Kang
Christian Medical College - Department of Pediatrics, Christian Medical College - Department of Pediatrics, Christian Medical College - The Wellcome Trust Research Laboratory, Christian Medical College - The Wellcome Trust Research Laboratory, Christian Medical College - The Wellcome Trust Research Laboratory, Christian Medical College - Department of Pediatrics, Christian Medical College - Department of Pediatrics, Christian Medical College - Department of Pediatrics, Christian Medical College - Department of Pediatrics, Christian Medical College - Department of Pediatrics, Christian Medical College - The Wellcome Trust Research Laboratory, Christian Medical College - Department of Community Medicine, Christian Medical College - Department of Infectious Diseases, Christian Medical College, Christian Medical College - Department of Community Medicine, CSIR-Centre for Cellular and Molecular Biology, Christian Medical College - The Wellcome Trust Research Laboratory and Christian Medical College
Downloads 118 (604,538)

Abstract:

Loading...

COVID-19, Vaccine trial, homologous booster, heterologous booster, ChAdOx1 nCoV-19, COVISHIELD, BBV152, COVAXIN, immunogenicity, safety